Why it Matters
The House Science, Space, and Technology Subcommittee on Environment will hold an environmental protection hearing Thursday, June 4 that focuses on the Trump administration's motions to dismantle the Environmental Protection Agency's (EPA) Office of Research and Development.
EPA scientists had published only 61 peer-reviewed studies in 2026 as of early May — a sharp decline from prior years, citing a nearly 20% decrease in publications from 2025, according to data from the nonprofit organization, Public Employees for Environmental Responsibility (PEER). PEER Science Policy Director Kyla Bennett put it plainly: "These numbers represent a diminution of scientific contributions from the fewer, remaining EPA scientists." The peer-reviewed publication decline is a traceable, documented consequence of the staffing reductions — not a theoretical concern.
The agency's long-standing research office, which spent decades producing science insulated from political pressure, has been replaced by a new entity called the Office of Applied Science and Environmental Solutions (OASES), housed directly within the Office of the Administrator. Critics argue that structural shift eliminates the independence that made ORD's work credible. The sole witness Thursday is Dr. Maureen Gwinn, the Deputy Associate Administrator for Science within OASES — making this effectively the new office's first major congressional audition.
The Big Picture
In July 2025, the Environmental Protection Agency announced it would dissolve ORD and replace it with OASES, claiming the reorganization would save about $749 million. The agency said the new office would "prioritize research and science more than ever before" and put science at the forefront of the agency's rule makings, according to its press office. But the relocation of the science function into the administrator's direct orbit — rather than maintaining it as a standalone office — has drawn sustained criticism from the scientific community and Democratic lawmakers alike.
Members of the science community have raised concerns on whether OASES satisfies the legal requirements of the 1978 Environmental Research, Development, and Demonstration Authorization Act, which mandates the EPA maintain a research function grounded in independent research through the best available science.
Political Stakes
For the Democrats
Two members of the subcommittee itself — Ranking Member Gabe Amo Jr. (D-RI-1) and Rep. Zoe Lofgren (D-CA-18) — have already gone on record opposing the ORD elimination, issuing a statement through the Democratic side of the House Science Committee's website. Their presence at Thursday's environmental protection hearing means the witness will face pointed questioning from members who have publicly staked out a position before the first gavel falls.
For the Public
The practical consequences of reduced EPA scientific output extend well beyond academic publication counts. EPA research underpins regulatory standards for air quality, drinking water, toxic chemicals, and climate-related environmental hazards. When the agency's scientific capacity shrinks, the evidentiary foundation for those rules weakens — creating legal vulnerability for existing regulations and raising the threshold for issuing new ones.
The structural question — whether OASES, sitting inside the administrator's office, can produce research with the same independence and credibility as a standalone ORD — matters for how courts, other agencies, and the public evaluate EPA science going forward. A research office that reports directly to a political appointee operates under different pressures than one with institutional separation.
The Bottom Line
This environmental science technology hearing fits into a wider pattern of congressional oversight over Trump administration changes to federal science infrastructure. Cuts at the National Oceanic and Atmospheric Administration, National Institute of Health, and other science agencies have drawn parallel scrutiny. The House Science, Space, and Technology Subcommittee has jurisdiction over federal research and development policy broadly, making the EPA restructuring a natural target for its oversight agenda.
The hearing carries no attached legislation — it is a fact-finding exercise. But the record it builds, and the answers Dr. Gwinn provides or declines to provide, will shape whether lawmakers pursue a legislative response to mandate ORD's restoration or codify requirements for scientific independence at the EPA.